インフルエンザ発症抑制における Oseltamivir の薬剤経済学的分析

DOI Web Site Web Site PubMed 参考文献10件

書誌事項

タイトル別名
  • Pharmacoeconomic Evaluation of Oseltamivir as Prophylaxis against Influenza Infection
  • インフルエンザ ハッショウ ヨクセイ ニ オケル Oseltamivir ノ ヤクザイ ケイザイガクテキ ブンセキ

この論文をさがす

抄録

  A pharmacoeconomic evaluation was made of prophylaxis against influenza using the oral neuraminidase inhibitor oseltamivir. Two patterns consisting of administration for 7 days as postcontact prophylaxis (7 day model) and seasonal administration for 6 weeks (6 week model) were examined. Decision analysis models were created on the basis of reports of clinical studies and epidemiologic studies relating to the drug and vaccination, and cost-effectiveness analyses were conducted based on the number of persons who had influenza and pneumonia as health outcomes. Costs were estimated with respect to health expenditures from the societal perspective as well as productivity costs. In the case of administration for 1-week postcontact prophylaxis, the health outcomes improved and costs were reduced in comparison with nontreatment, thus making this administration schedule the dominant choice. With administration for 6 weeks during the infectious period, vaccination involved lower costs and was superior in terms of health outcomes.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 124 (4), 207-216, 2004-04-01

    公益社団法人 日本薬学会

参考文献 (10)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ